Veterinary CRO

Veterinary CRO

Global Veterinary CRO Market to Reach US$984.5 Million by 2030

The global market for Veterinary CRO estimated at US$664.6 Million in the year 2023, is expected to reach US$984.5 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Clinical Trials, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$362.8 Million by the end of the analysis period. Growth in the Toxicology segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$181.1 Million While China is Forecast to Grow at 9.6% CAGR

The Veterinary CRO market in the U.S. is estimated at US$181.1 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$211.8 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Veterinary CRO Market - Key Trends and Drivers Summarized

Veterinary Contract Research Organizations (CROs) are pivotal in advancing veterinary medicine, providing essential services for the development and testing of new veterinary drugs, treatments, and products. These organizations operate similarly to human clinical research organizations but are focused on animal health. Veterinary CROs offer a range of services including preclinical and clinical trial management, regulatory support, data management, and market analysis. These services are crucial for pharmaceutical companies, biotechnology firms, and academic researchers looking to bring new veterinary products to market. By outsourcing these tasks to specialized CROs, these entities can focus on their core competencies, such as product innovation and strategic marketing, while leveraging the expertise of CROs to ensure compliance with regulatory standards and achieve scientifically sound trial results.

The operational landscape for veterinary CROs is becoming increasingly sophisticated with advancements in technology and methodology. Innovations in veterinary healthcare, such as the use of wearable technology for real-time health monitoring in clinical trials, and the application of advanced imaging techniques, are improving the efficiency and effectiveness of drug development and testing processes. Additionally, there is a growing emphasis on developing personalized medicine solutions for pets, mirroring trends in human healthcare. This involves tailoring therapies to individual genetic profiles, which demands more specialized research and data analysis services from CROs. The expansion of the market is also facilitated by increased investment in pet care and livestock health products, driven by the rising demand for protein and dairy products, and an increasing pet ownership rate globally. These factors necessitate a broad range of services from veterinary CROs to support product development and ensure regulatory compliance across different markets.

The growth in the veterinary CRO market is driven by several factors, including the increasing investment in animal health by pharmaceutical companies, rising demand for livestock products, and the growing trend of pet humanization where pets are considered an integral part of the family. This shift in consumer behavior increases the demand for advanced veterinary care solutions, driving the need for more rigorous and extensive product development cycles. Technological advancements such as telemedicine, big data, and AI are also propelling the market by enhancing the range and quality of services offered by veterinary CROs. These technologies enable more efficient data collection and analysis, improved monitoring and management of clinical trials, and greater predictive capabilities. Furthermore, regulatory changes demanding more stringent safety standards for veterinary products stimulate the need for professional and specialized services provided by CROs. As global standards and consumer expectations rise, the role of veterinary CROs becomes increasingly crucial in helping companies navigate the complex landscape of product development and approval. This dynamic convergence of technology, consumer expectations, and regulatory frameworks ensures sustained growth and innovation within the veterinary CRO industry.

Select Competitors (Total 86 Featured) -

• Argenta Limited
• Cebiphar
• Charles River Laboratories International, Inc.
• IDEXX BioAnalytics
• KLIFOVET GmbH
• Laboratory Corporation of America Holdings
• Löhlein & Wolf vet research
• OCRvet
• Ondax Scientific, SL
• Ridgeway Research Ltd
• Royal GD
• STATKING Clinical Services
• Veterinary Research Management
• Vetspin Srl
• Vivotecnia Research S.L;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.